Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1955 1
1956 1
1957 1
1959 1
1960 2
1961 2
1962 3
1963 4
1964 6
1965 21
1966 10
1967 10
1968 10
1969 9
1970 7
1971 17
1972 17
1973 15
1974 24
1975 19
1976 16
1977 22
1978 26
1979 25
1980 38
1981 37
1982 51
1983 61
1984 60
1985 56
1986 65
1987 68
1988 56
1989 73
1990 57
1991 57
1992 64
1993 85
1994 105
1995 91
1996 112
1997 104
1998 152
1999 133
2000 133
2001 120
2002 149
2003 142
2004 122
2005 121
2006 135
2007 143
2008 132
2009 144
2010 190
2011 189
2012 238
2013 220
2014 218
2015 193
2016 188
2017 209
2018 236
2019 253
2020 308
2021 349
2022 270
2023 236
2024 107

Text availability

Article attribute

Article type

Publication date

Search Results

5,944 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Nivolumab in Resectable Lung Cancer.
Cascone T, Awad MM, Spicer JD, He J, Lu S, Sepesi B, Tanaka F, Taube JM, Cornelissen R, Havel L, Karaseva N, Kuzdzal J, Petruzelka LB, Wu L, Pujol JL, Ito H, Ciuleanu TE, de Oliveira Muniz Koch L, Janssens A, Alexandru A, Bohnet S, Moiseyenko FV, Gao Y, Watanabe Y, Coronado Erdmann C, Sathyanarayana P, Meadows-Shropshire S, Blum SI, Provencio Pulla M; CheckMate 77T Investigators. Cascone T, et al. N Engl J Med. 2024 May 16;390(19):1756-1769. doi: 10.1056/NEJMoa2311926. N Engl J Med. 2024. PMID: 38749033 Clinical Trial.
Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era.
Shindo T, Hashimoto K, Fujino K, Takahashi A, Hotta H, Maeda T, Kunishima Y, Fukuta F, Ito N, Wanifuchi A, Kato R, Okada M, Matsukawa M, Horita H, Takayanagi A, Kobayashi K, Tanaka T, Masumori N. Shindo T, et al. Among authors: okada m. World J Urol. 2024 May 9;42(1):307. doi: 10.1007/s00345-024-04952-z. World J Urol. 2024. PMID: 38722418
Impact of Age 70 years or Older on Donors for Living-Donor Kidney Transplantation.
Hiramitsu T, Himeno T, Hasegawa Y, Futamura K, Okada M, Matsuoka Y, Goto N, Ichimori T, Narumi S, Takeda A, Kobayashi T, Uchida K, Watarai Y. Hiramitsu T, et al. Among authors: okada m. Kidney Int Rep. 2024 Feb 1;9(5):1321-1332. doi: 10.1016/j.ekir.2024.01.043. eCollection 2024 May. Kidney Int Rep. 2024. PMID: 38707796 Free PMC article.
5,944 results